Abstract
The subcellular localization, efficacy and photooxidative mechanism of three new photosensitizing porphycenes (HexoTMPn, PeloTMPn, CpoTMPn) for photodynamic therapy with different substituents at position 9 of the tetrapyrrole macrocycle were investigated in vitro using different human skin-derived cell lines (HaCaT, SCL I, SCL II) with the aim of customizing the side-chain chemistry to accelerate cellular uptake and so enhance photodynamic activity. Cells were incubated with a porphycene and costained with organelle-specific markers. Subcellular localization was determined by fluorescence microscopy. Also, cells were incubated with different sensitizer concentrations (0–1000 nmol/l) and irradiated by an incoherent light source (λem = 600–750 nm, 40 mW/cm2, 24 J/cm2) with/without quenchers or enhancers (NaN3, histidine, mannitol or D2O). Cell viability was assessed. All porphycenes were localized in perinuclear lysosomes and induced a decrease in mitochondrial activity following irradiation. HexoTMPn was the most efficient in all three cell lines (EC50 in HaCaT cells: HexoTMPn 14 nmol/l, CpoTMPn 62 nmol/l, PeloTMPn 89 nmol/l). Addition of either NaN3 or histidine reduced the phototoxicity significantly. Due to the short lifetime of singlet oxygen, the sites of sensitizer localization are the initial subcellular targets. The cytotoxicity of each sensitizer varied depending on singlet oxygen quantum yield and cell line. Despite the different chemical structures, the biological effects were not very distinct, since they seemed to be mostly determined by the tetrapyrrole ring and only slightly modified by the substituent at position 9. Also, there was only a narrow margin between biological compatibility and efficacy.
Similar content being viewed by others
References
Abels C, Szeimies RM, Steinbach P, Richert C, Goetz AE (1997) Targeting of the tumor microcirculation by photodynamic therapy with a synthetic porphycene. J Photochem Photobiol 40:305–312
Aramedia PF, Redmond RW, Nonell S, Schuster W, Braslavsky SE, Schaffner K, Vogel E (1986) The photophysical properties of porphycenes: potential photodynamic therapy agents. Photochem Photobiol 44:555–559
Aveline BM (2001) Primary processes in photosensitization mechanisms. In: Calzavara-Pinton P, Szeimies RM, Ortel B (eds) Photodynamic therapy and fluorescence diagnosis in dermatology. Elsevier Science, Amsterdam, pp 17–37
Baker A, Kanovsky JR (1993) Time-resolved studies of singlet-oxygen emission from L1210 leukemia cells labeled with 5-(N-hexadecanoyl)amino eosin. A comparison with a one-dimensional model of singlet-oxygen diffusion and quenching. Photochem Photobiol 57:720–727
Bakri SJ, Kaiser PK (2004) Verteporfin ocular photodynamic therapy. Expert Opin Pharmacother 5:195–203
Bellnier DA, Ho YK, Pandey RK, Missert JR, Dougherty TJ (1989) Distribution and elimination of photofrin II in mice. Photochem Photobiol 50:221–228
Boukamp P, Tilgen W, Dzarlieva RT, Breitkreuz D, Haag D, Riehl RK, Bohnert A, Fusenig NE (1982) Phenotypic and genotypic characteristics of a cell line from a squamous cell carcinoma of the human skin. J Natl Cancer Inst 68:415–427
Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte. J Cell Biol 106:761–771
Braslavsky SE, Müller M, Martire DO, Pörting S, Bertolotti S, Charkravorti S, Koc-Weier G, Knipp B, Schaffner K (1997) Photophysical properties of porphycene derivatives (18 π porphinoids). J Photochem Photobiol 40:191–198
Dellian M, Abels C, Kuhnle GEH, Goetz AE (1995) Effects of photodynamic therapy on leucocyte-endothelium interaction: differences between normal and tumor tissue. Br J Cancer 72:1125–1130
Dixit R, Mukhtar H, Bickers DR (1983) Studies on the role of reactive oxygen species in mediating lipid peroxide formation in epidermal microsomes of rat skin. J Invest Dermatol 81:369–375
Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3:380–387
Dougherty TJ (1986) Photosensitization of malignant tumors. Semin Surg Oncol 2:24–27
Fickweiler S, Abels C, Karrer S, Bäumler W, Landthaler M, Hofstädter F, Szeimies RM (1999) Photosensitization of human skin cell lines by ATMPn (9-acetoxy-2,7,12,17-tetrakis-(β-methoxyethyl)-porphycene) in vitro: mechanism of action. J Photochem Photobiol B 48:27–35
Haller T, Dietl P, Deetjen P, Volkl H (1996) The lysosomal compartment as intracellular calcium store in MDCK cells: a possible involvement in InsP3-mediated Ca2+ release. Cell Calcium 19:157–165
Ito T (1978) Cellular and subcellular mechanisms of photodynamic action: the 1O2 hypothesis as a driving force in recent research. Photochem Photobiol 28:493–508
Karrer S (2001) Topical sensitization—non-oncologic indications—others (scleroderma, sarcoidosis, eczema). In: Calzavara-Pinton P, Szeimies RM, Ortel B (eds) Photodynamic therapy and fluorescence diagnosis in dermatology. Elsevier Science, Amsterdam, pp 301–306
Karrer S, Szeimies RM, Ebert A, Fickweiler S, Abels C, Bäumler W, Landthaler M (1997) Dose-dependent photodynamic effects of 9-acetoxy-2,7,12,17-tetrakis-(β-methoxyethyl)-porphycene in vitro. Lasers Med Sci 12:307–312
Karrer S, Abels C, Landthaler M, Szeimies RM (2000) Topical photodynamic therapy for localized scleroderma. Acta Derm Venereol 80:26–27
Kessel D, Luo Y (1998) Mitochondrial photodamage and PDT-induced apoptosis. J Photochem Photobiol B 42:89–95
Kilger R, Maier M, Szeimies RM, Bäumler W (2001) Bidirectional energy transfer between the triplet T1 state of photofrin and singlet oxygen in deuterium oxide. Chem Phys Lett 343:543–548
Landthaler M, Rück A, Szeimies RM (1993) Photodynamische Therapie von Tumoren der Haut. Hautarzt 44:69–74
Leunig M, Richert C, Gamarra F, Lumper W, Vogel E, Jocham D, Goetz AE (1993) Tumor localization kinetics of photofrin and three synthetic porphyrinoids in an amelanotic melanoma of the hamster. Br J Cancer 68:225–234
McCaughan JS Jr, Guy JT, Hicks W (1989) Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms. Arch Surg 124:211–216
McHale AP, McHale l (1988) Use of a tetrazolium based colorimetric assay in assessing photoradiation therapy in vitro. Cancer Lett 41:315–321
Niks M, Otto M (1990) Towards an optimized MTT assay. J Immunol Methods 130:149–151
Pass HI (1993) Photodynamic therapy in oncology: mechanism and clinical use. J Natl Cancer Inst 85:443–456
Penning LC, Dubbelman TMAR (1994) Fundamentals of photodynamic therapy: cellular and biochemical aspects. Anticancer Drugs 5:139–146
Pogue BW, Ortel B, Chen N, Redmond RW, Hasa T (2001) A photobiological and photophysical-based study of phototoxicity of two chlorines. Cancer Res 91:717–724
Richert C, Wessels JM, Müller M, Kisters M, Benninghaus T, Goetz AE (1994) Photodynamic antitumor agents: β-methoxyethyl groups give access to functionalized porphycenes and enhance cellular uptake and activity. J Med Chem 37:2792–2807
Robins E, Marcus PI (1963) Dynamics of acridine orange-cell interaction, I. Interrelationships of acridine orange particles and cytoplasmic reddening. J Cell Biol 18:237–250
Robins E, Marcus PI, Gonatas NK (1964) Dynamics of acridine orange-cell interaction, II. Dye-induced ultrastructural changes in multivesicular bodies (acridine orange particles). J Cell Biol 21:49–62
Rougée M, Bensasson RV (1986) Détermination des constantes de vitesse de désactivation de l’oxygéne singulet (1Δg) en présence de biomolécules. CR Acad Sci Paris, t 302, Série II, no. 20, pp 1223–1226
Star WM, Marijnissen HP, van den Berg-Blok AE, Versteeg JA, Franken KA, Reinhold HS (1986) Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res 46:2532–2540
Szeimies RM, Hein R, Bäumler W, Heine A, Landthaler M (1994) A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol 74:117–119
Szeimies RM, Abels C, Fritsch C, Karrer S, Steinbach P, Bäumler W, Goerz G, Goetz AE, Landthaler M (1995) Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo. J Invest Dermatol 105:672–677
Szeimies RM, Karrer S, Abels C, Steinbach P, Fickweiler S, Messmann H, Bäumler W, Landthaler M (1996) 9-Acetoxy-2,7,12,17-tetrakis-(β-methoxyethyl)-porphycene (ATMPn), a novel photosensitizer for photodynamic therapy: uptake kinetics and intracellular localisation. J Photochem Photobiol B 34:67–72
Tilgen W, Boukamp P, Breitkreutz D, Dzarlieva RT, Engstner M, Haag D, Fusenig NE (1983) Preservation of morphological, functional, and karyotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas. Cancer Res 43:5995–6011
Vogel E, Köcher M, Schmickler H, Lex J (1986) Porphycene—a novel porphin isomer. Angew Chem 98:262–264
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scherer, K., Abels, C., Bäumler, W. et al. Structure-activity relationships of three differently substituted 2,7,12,17-tetrakis-(β-methoxyethyl) porphycene derivatives in vitro. Arch Dermatol Res 295, 535–541 (2004). https://doi.org/10.1007/s00403-004-0458-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-004-0458-3